ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1,6,Pruritus allergic,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1,7,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3,1,Aspartate aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3,6,Gamma-glutamyltransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3,7,Haemoglobin abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3,8,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3,9,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3,10,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
3,11,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
3,12,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
3,13,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
3,14,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,15,Neutrophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3,16,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3,17,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
3,18,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
6,1,Aspartate aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
6,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
6,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6,7,Gamma-glutamyltransferase,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
6,8,Haemoglobin,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
6,9,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
6,10,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
6,11,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
6,12,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
6,13,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6,14,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6,15,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
6,16,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
6,17,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6,18,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
6,19,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
6,20,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6,21,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6,22,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
6,23,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
6,24,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
7,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
8,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
8,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
8,5,Isocitrate dehydrogenase gene mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
8,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8,7,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
8,8,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
9,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
9,2,TP53 gene mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
